Patents-Review.com
ClassID:

110230 ⎘

C12N2730/10134 - CPC Classification

Classification description:

Reverse transcribing DNA viruses; Details; Hepadnaviridae; Orthohepadnavirus, e.g. hepatitis B virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260137774
2026-05-21

Hepatitis B Virus Receptor OATP and Use Thereof

 #2
20260069683
2026-03-12

PHARMACEUTICAL COMPOSITION FOR PREVENTING HEPATITIS B VIRUS INFECTION AND USE THEREOF

 #3
20260053910
2026-02-26

HBV VACCINES AND METHODS TREATING HBV

 #4
20260053900
2026-02-26

USE OF VIRUS-LIKE PARTICLES IN VACCINATION

 #5
20250333450
2025-10-30

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION

 #6
20250242014
2025-07-31

HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS

 #7
20250228934
2025-07-17

ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME

 #8
20250145669
2025-05-08

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION

 #9
20250144202
2025-05-08

GLYCOSYL-MODIFIED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL AND APPLICATIONS THEREOF

 #10
20250101083
2025-03-27

EPITOPE PEPTIDE AND ANTIBODY FOR TREATING HBV INFECTION AND RELATED DISEASES

 #11
20250073332
2025-03-06

LENTIVIRAL VECTOR, LENTIVIRAL PARTICLE FOR TREATING HEPATITIS B AND ITS PREPARATION METHOD AND APPLICATION THEREOF

 #12
20250000968
2025-01-02

SARS-COV-2 SPIKE FUSED TO A HEPATITIS B SURFACE ANTIGEN

 #13
20240390473
2024-11-28

CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES

 #14
20240382584
2024-11-21

HBV VACCINE INDUCING PRES-SPECIFIC NEUTRALIZING ANTIBODIES

 #15
20240382583
2024-11-21

HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS

 #16
20240335531
2024-10-10

MULTI-ANTIGEN THERAPEUTIC VACCINES TO TREAT OR PREVENT CHRONIC HEPATITIS B VIRUS INFECTION

 #17
20240269267
2024-08-15

SYNTHETIC DNA VACCINE IMMUNOGENIC IMPROVEMENTS

 #18
20240216502
2024-07-04

Universal vaccine platform

 #19
20240189353
2024-06-13

MODULATED IMMUNODOMINANCE THERAPY

 #20
20240150412
2024-05-09

Methods and compositions for the treatment of hepatitis B infection

 #21
20240123061
2024-04-18

Therapeutic Vaccine for Hepatitis B Virus (HBV) using the HBV Core Antigen

 #22
20240115694
2024-04-11

HBV VACCINE

 #23
20240091347
2024-03-21

Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same

 #24
20240066117
2024-02-29

HBV VACCINES AND METHODS TREATING HBV

 #25
20240058439
2024-02-22

NANOEMULSION COMPOSITIONS FOR PREVENTING, SUPPRESSING OR ELIMINATING ALLERGIC AND INFLAMMATORY DISEASE

 #26
20230242590
2023-08-03

TREATMENT OF DISEASES RELATED TO HEPATITIS B VIRUS

 #27
20230165950
2023-06-01

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

 #28
20230114007
2023-04-13

HBV vaccines and methods treating HBV

 #29
20230090379
2023-03-23

Vaccines against hepatitis B virus

 #30
20230063089
2023-03-02

ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME

 #31
20220347295
2022-11-03

Vaccine delivery method

 #32
20220324916
2022-10-13

Hepatitis B Virus (HBV) Vaccines and Uses Thereof

 #33
20220305107
2022-09-29

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi

 #34
20220288195
2022-09-15

HEPATITIS B VIRUS VACCINES

 #35
20220241403
2022-08-04

Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen

 #36
20220226460
2022-07-21

Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

 #37
20220193230
2022-06-23

COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME

 #38
20220175913
2022-06-09

Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same

 #39
20220175912
2022-06-09

Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use

 #40
20220118082
2022-04-21

Compositions and methods for generating an immune response to hepatitis B virus

 #41
20220054631
2022-02-24

MHC Class I Associated Hepatitis B Peptides

 #42
20220048955
2022-02-17

Fusion Protein

 #43
20220016231
2022-01-20

HEPATITIS B VIRUS VACCINE AND USES THEREOF

 #44
20220002349
2022-01-06

Methods and compositions for the treatment of hepatitis B infection

 #45
20210401975
2021-12-30

Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease

 #46
20210393769
2021-12-23

CORONAVIRUS VACCINE AND METHODS OF USE THEREOF

 #47
20210355168
2021-11-18

CHIMERIC ANTIGEN WITH ENHANCED MULTI-IMMUNE FUNCTION THROUGH SPECIFIC BINDING TO TARGET CELL, AND USE THEREOF

 #48
20210330785
2021-10-28

Universal vaccine platform

 #49
20210283246
2021-09-16

Method for efficiently inducing antibody, antibody and detection system for hepatitis virus

 #50
20210269778
2021-09-02

Hepatitis B virus (HBV) vaccines and uses thereof

 #51
20210268104
2021-09-02

Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV)

 #52
20210236626
2021-08-05

Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines contaning hepatitis B virus genes

 #53
20210189421
2021-06-24

Replication competent adenoviral vectors

 #54
20210154290
2021-05-27

Hepatitis B immunization regimen and compositions

 #55
20210128718
2021-05-06

Treatment and prevention of house dust mite allergies

 #56
20210122787
2021-04-29

Tetravalent dengue vaccine

 #57
20210093712
2021-04-01

HBV vaccines and methods treating HBV

 #58
20210015916
2021-01-21

Vaccine delivery method

 #59
20210002813
2021-01-07

Lipid nanoparticle vaccine adjuvants and antigen delivery systems

 #60
20200306367
2020-10-01

Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen

 #61
20200306353
2020-10-01

Methods for inducing an immune response

 #62
20200181142
2020-06-11

Derivatives And Methods Of Treating Hepatitis B Infections

 #63
20200164062
2020-05-28

Virus-like particles including HBs-L antigen protein for causing immune response against HBV

 #64
20200147206
2020-05-14

STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS

 #65
20200147205
2020-05-14

Polypeptide carrier for presenting target polypeptide and uses thereof

 #66
20200138927
2020-05-07

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

 #67
20200113998
2020-04-16

HBV VACCINE

 #68
20200113996
2020-04-16

Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

 #69
20200101147
2020-04-02

POLYPEPTIDE VACCINE

 #70
20200085943
2020-03-19

Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen

 #71
20200054731
2020-02-20

Immunomodulatory compositions and methods of use thereof

 #72
20200016263
2020-01-16

Vaccines against Hepatitis B virus

 #73
20200000911
2020-01-02

IMMUNOGENIC COMPOSITION

 #74
20190389912
2019-12-26

Fusion proteins and use thereof for preparing vaccines

 #75
20190338014
2019-11-07

Fusion peptides with antigens linked to short fragments of invariant chain(CD74)

 #76
20190336596
2019-11-07

Universal vaccine platform

 #77
20190314494
2019-10-17

Synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B virus infection

 #78
20190307875
2019-10-10

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

 #79
20190298822
2019-10-03

Immunogenic composition

 #80
20190248844
2019-08-15

Polypeptide construct comprising fragments of allergens

 #81
20190240323
2019-08-08

Branched chimeric compounds, and methods of use thereof

 #82
20190216921
2019-07-18

Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg

 #83
20190194280
2019-06-27

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

 #84
20190194261
2019-06-27

Tetravalent dengue vaccine

 #85
20190194191
2019-06-27

Derivatives and methods of treating hepatitis B infections

 #86
20190185828
2019-06-20

Hepatitis B virus (HBV) vaccines and uses thereof

 #87
20190184011
2019-06-20

Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)

 #88
20190184010
2019-06-20

Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines

 #89
20190184009
2019-06-20

Compositions and methods for generating an immune response to hepatitis B virus

 #90
20190160173
2019-05-30

Oligonucleotide constructs and uses thereof

 #91
20190153042
2019-05-23

Antimicrobial peptides derived from hepatitis B virus core protein arginine-rich domain

 #92
20190151443
2019-05-23

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

 #93
20190144840
2019-05-16

Methods for treating or preventing HBV infection or HBV related diseases

 #94
20190134190
2019-05-09

COMBINATION THERAPY WITH CPG TLR9 LIGAND

 #95
20190099479
2019-04-04

Recombinant HCMV and RHCMV vectors and uses thereof

 #96
20190083608
2019-03-21

Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine

 #97
20190083607
2019-03-21

Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes

 #98
20190077800
2019-03-14

Derivatives and methods of treating hepatitis B infections

 #99
20190070286
2019-03-07

METHOD OF VACCINATION

 #100
20190070285
2019-03-07

Composition for treating HBV infection

 #101
20190038740
2019-02-07

MHC class I associated hepatitis B peptides

 #102
20190031653
2019-01-31

Derivatives and methods of treating hepatitis B infections

 #103
20190030158
2019-01-31

Means and methods for treating HBV

 #104
20180360954
2018-12-20

Linear chimeric compounds and methods of use thereof

 #105
20180354993
2018-12-13

Cyclic NTCP-targeting peptides and their uses as entry inhibitors

 #106
20180333485
2018-11-22

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

 #107
20180319845
2018-11-08

Vaccines against hepatitis B virus

 #108
20180311339
2018-11-01

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #109
20180256695
2018-09-13

COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT

 #110
20180244739
2018-08-30

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

 #111
20180244726
2018-08-30

Fusion Protein

 #112
20180243407
2018-08-30

Methods and compositions for eliciting an immune response against hepatitis B virus

 #113
20180169223
2018-06-21

Vaccine adjuvant composition comprising inulin particles

 #114
20180169204
2018-06-21

Combination vaccines with lower doses of antigen and/or adjuvant

 #115
20180127415
2018-05-10

Derivatives and methods of treating hepatitis B infections

 #116
20180126001
2018-05-10

ANTIBODY-VACCINE ENGINEERED CONSTRUCTS (AVEC)

 #117
20180078636
2018-03-22

Hepatitis B therapeutic vaccines

 #118
20180078635
2018-03-22

Vaccine formulation, preparation method therefor and use thereof

 #119
20180064806
2018-03-08

Immunogenic composition

 #120
20180028635
2018-02-01

COMPOSITION AND USES THEREOF

 #121
20180015160
2018-01-18

In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus-Like Particles

 #122
20180002382
2018-01-04

Polypeptides and antibodies for treating HBV infection and related diseases

 #123
20170296639
2017-10-19

METHOD FOR PREPARING DENDRITIC CELL LOADED WITH ANTIGEN

 #124
20170258900
2017-09-14

Immunostimulating Polyphosphazene Compounds

 #125
20170258895
2017-09-14

DNA-peptide combination vaccine

 #126
20170246294
2017-08-31

Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease

 #127
20170246293
2017-08-31

Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B virus infection

 #128
20170240601
2017-08-24

Tetravalent dengue vaccine

 #129
20170216573
2017-08-03

INJECTION NEEDLE AND DEVICE

 #130
20170216357
2017-08-03

Modulated immunodominance therapy

 #131
20170202954
2017-07-20

Stabilization of Aqueous Compositions of Proteins With Displacement Buffers

 #132
20170158691
2017-06-08

Derivatives and methods of treating hepatitis B infections

 #133
20170151319
2017-06-01

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

 #134
20170145392
2017-05-25

HBV polymerase mutants

 #135
20170136120
2017-05-18

INDUCTION OF IMMUNE RESPONSE

 #136
20170136119
2017-05-18

Pharmaceutical compositions comprising CpG oligonucleotides

 #137
20170136110
2017-05-18

Methods for inducing an immune response

 #138
20170121329
2017-05-04

Derivatives and methods of treating hepatitis B infections

 #139
20170121328
2017-05-04

Derivatives and methods of treating hepatitis B infections

 #140
20170112914
2017-04-27

Methods for inducing an immune response

 #141
20170101625
2017-04-13

MODULATED IMMUNODOMINANCE THERAPY

 #142
20170095553
2017-04-06

Method of obtaining a polyepitopic protein and polyepitopic DNA vector

 #143
20170087245
2017-03-30

Methods and compositions for eliciting an immune response against hepatitis B virus

 #144
20170072047
2017-03-16

Composition for Treating HBV Infection

 #145
20170072035
2017-03-16

Tumor vaccination involving a humoral immune response against self-proteins

 #146
20170065715
2017-03-09

Vaccine compositions comprising a saponin adjuvant

 #147
20170065714
2017-03-09

Immunogenic composition

 #148
20170058003
2017-03-02

IMMUNOGEN PLATFORM

 #149
20170056493
2017-03-02

Virus like vesicles (VLVS) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection

 #150
20170049871
2017-02-23

Vaccines based on hepatitis B core antigens

 #151
20170043000
2017-02-16

MODULATED IMMUNODOMINANCE THERAPY

 #152
20170042999
2017-02-16

MODULATED IMMUNODOMINANCE THERAPY

 #153
20170042998
2017-02-16

MODULATED IMMUNODOMINANCE THERAPY

 #154
20170035864
2017-02-09

SPECIFIC VIRUS-LIKE PARTICLE-CpG OLIGONUCLEOTIDE VACCINES AND USES THEREOF

 #155
20170029470
2017-02-02

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

 #156
20170007695
2017-01-12

Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex

 #157
20170000879
2017-01-05

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #158
20160361411
2016-12-15

Lipid nanoparticle vaccine adjuvants and antigen delivery systems

 #159
20160361410
2016-12-15

MHC class I associated peptides for prevention and treatment of hepatitis B virus infection

 #160
20160317652
2016-11-03

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

 #161
20160317637
2016-11-03

Immunomodulatory compositions and methods of use thereof

 #162
20160311862
2016-10-27

EPITOPE AND ITS USE OF HEPATITIS B VIRUS SURFACE ANTIGEN

 #163
20160235840
2016-08-18

Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

 #164
20160229896
2016-08-11

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

 #165
20160213774
2016-07-28

Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof

 #166
20160206715
2016-07-21

SPECIFIC MULTIVALENT VIRUS-LIKE PARTICLE VACCINES AND USES THEREOF

 #167
20160200758
2016-07-14

1,2,3-triazole-tethered carbohydrate-di and tri lipidated cysteine conjugates useful as vaccine adjuvants and process for preparation thereof

 #168
20160193327
2016-07-07

Mucosal vaccine composition

 #169
20160185779
2016-06-30

Derivatives and methods of treating hepatitis B infections

 #170
20160185778
2016-06-30

Derivatives and methods of treating hepatitis B infections

 #171
20160185777
2016-06-30

Derivatives and methods of treating hepatitis B infections

 #172
20160144011
2016-05-26

Composition and uses thereof

 #173
20160136265
2016-05-19

Pharmaceutical composition for viral immunotherapy and uses thereof

 #174
20160136264
2016-05-19

Hepatitis B vaccine

 #175
20160122420
2016-05-05

ANTIBODY DISPLAY

 #176
20160114030
2016-04-28

Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same

 #177
20160106833
2016-04-21

Immunostimulating polyphosphazene compounds

 #178
20160106830
2016-04-21

Vaccines against hepatitis B virus

 #179
20160068581
2016-03-10

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

 #180
20160060358
2016-03-03

INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE

 #181
20160051664
2016-02-25

Recombinant polynucleotide and a transgenic carrying the same

 #182
20160038433
2016-02-11

Nanocapsules of protamine

 #183
20160032410
2016-02-04

Detection and use of antiviral resistance mutations

 #184
20160022801
2016-01-28

Rodent hepadnavirus cores with reduced carrier-specific antigenicity

 #185
20160015804
2016-01-21

Vaccine combinations

 #186
20160008460
2016-01-14

Vaccination strategy

 #187
20160002300
2016-01-07

Antimicrobial peptides derived from hepatitis B virus core protein arginine-rich domain

 #188
20150344529
2015-12-03

VACCINE FOR HPV INFECTION AND/OR HEPATITIS B COMPRISING HPV/HBS CHIMERIC PROTEIN AS ACTIVE INGREDIENT

 #189
20150335735
2015-11-26

Peptide carrier fusion proteins as allergy vaccines

 #190
20150320855
2015-11-12

IN VIVO ACTIVATION OF ANTIGEN PRESENTING CELLS FOR ENHANCEMENT OF IMMUNE RESPONSES INDUCED BY VIRUS-LIKE PARTICLES

 #191
20150306196
2015-10-29

Polypeptide vaccine

 #192
20150273047
2015-10-01

VACCINE

 #193
20150273036
2015-10-01

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

 #194
20150259111
2015-09-17

Method of storing a vaccine containing an aluminum adjuvant

 #195
20150252084
2015-09-10

COMPOSITIONS AND METHODS THAT ENHANCE AN IMMUNE RESPONSE

 #196
20150246948
2015-09-03

Polypeptides and antibodies for treating HBV infection and related diseases

 #197
20150238600
2015-08-27

Immunostimulating Polyphosphazene Compounds

 #198
20150202271
2015-07-23

DNA vaccine containing VEGF-specific epitope and/or angiopoietin-2-specific epitope

 #199
20150191509
2015-07-09

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #200
20150174239
2015-06-25

Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine

 #201
20150152154
2015-06-04

Tumor vaccination involving a humoral immune response against self-proteins

 #202
20150118264
2015-04-30

PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN

 #203
20150110828
2015-04-23

Yeast-based therapeutic for chronic hepatitis B infection

 #204
20150086610
2015-03-26

Immunostimulatory oligonucleotides

 #205
20150044253
2015-02-12

Immunogenic composition

 #206
20150037368
2015-02-05

Polyanionic polymer adjuvants for Haemophilus influenzae B saccharide vaccines

 #207
20150004194
2015-01-01

Facilitator-DNA combination vaccine

 #208
20140370049
2014-12-18

Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxide

 #209
20140341980
2014-11-20

Method to enhance an immune response of nucleic acid vaccination

 #210
20140339126
2014-11-20

Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

 #211
20140335110
2014-11-13

Laser-based vaccine adjuvants

 #212
20140316122
2014-10-23

Hepatitis B virus vaccines

 #213
20140287480
2014-09-25

HBV polymerase mutants

 #214
20140286984
2014-09-25

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #215
20140193450
2014-07-10

Peptide carrier fusion proteins as allergy vaccines

 #216
20140134204
2014-05-15

Methods of improving vaccine immunogenicity

 #217
20140127255
2014-05-08

Chimeric immunomodulatory compounds and methods of using the same-IV

 #218
20140112923
2014-04-24

Epitope and its use of hepatitis B virus surface antigen

 #219
20140105992
2014-04-17

Vaccine

 #220
20140099358
2014-04-10

Vaccines with enhanced immune response and methods for their preparation

 #221
20140065182
2014-03-06

Yeast-based therapeutic for chronic hepatitis B infection

 #222
20140023682
2014-01-23

Cancer inhibiting agent, antibody production enhancing agent, and therapeutic agent for hepatitis

 #223
20140023613
2014-01-23

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

 #224
20130323281
2013-12-05

Ordered flagellin array as an immunostimulant

 #225
20130280293
2013-10-24

Combination heptavalent vaccine

 #226
20130273101
2013-10-17

Vaccine for inducing an improved immune reaction

 #227
20130209395
2013-08-15

Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same

 #228
20130195910
2013-08-01

Vaccine delivery method

 #229
20130136758
2013-05-30

Immunostimulating Polyphosphazene Compounds

 #230
20130052217
2013-02-28

Tumor vaccination involving a humoral immune response against self-proteins

 #231
20130039958
2013-02-14

METHOD OF VACCINATION

 #232
20130011435
2013-01-10

Composition for treating HBV infection

 #233
20130004536
2013-01-03

Multiple vaccination including serogroup C meningococcus

 #234
20130004535
2013-01-03

Multiple vaccination including serogroup C meningococcus

 #235
20130004532
2013-01-03

Process for manufacturing vaccines

 #236
20120321659
2012-12-20

HBV CORE ANTIGEN PARTICLES WITH MULTIPLE IMMUNOGENIC COMPONENTS ATTACHED VIA PEPTIDE LIGANDS

 #237
20120308615
2012-12-06

FORMULATION OF HEPATITIS B VIRUS ANTIGENS FOR CELLULAR STIMULATION FOLLOWED BY THERAPEUTIC IMMUNIZATION

 #238
20120282284
2012-11-08

METHODS AND COMPOSITIONS FOR PRODUCING ANTIGENIC RESPONSES

 #239
20120263755
2012-10-18

Methods and compositions for eliciting an immune response against hepatitis B virus

 #240
20120258137
2012-10-11

IMMUNOGENIC COMPOSITIONS COMPRISING NANOEMULSION AND HEPATITIS B VIRUS IMMUNOGEN AND METHODS OF USING THE SAME

 #241
20120251569
2012-10-04

Composition for treating HBV infection

 #242
20120231039
2012-09-13

Chimeric immunomodulatory compounds and methods of using the same-IV

 #243
20120219589
2012-08-30

Formulation of drugs and vaccines in the form of percutaneous injectable needles

 #244
20120219586
2012-08-30

Adjuvanted vaccine formulations

 #245
20120208870
2012-08-16

HEPATITIS C VIRUS CODON OPTIMIZED NON-STRUCTURAL NS3/4A FUSION GENE

 #246
20120207780
2012-08-16

Vaccine composition

 #247
20120195937
2012-08-02

POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES

 #248
20120195926
2012-08-02

METHODS OF IMPROVING VACCINE IMMUNOGENICITY

 #249
20120156240
2012-06-21

Methods for preparing vesicles and formulations produced therefrom

 #250
20120121713
2012-05-17

Chimeric therapeutics, compositions, and methods for using same

 #251
20120121690
2012-05-17

Method to enhance an immune response of nucleic acid vaccination

 #252
20120107349
2012-05-03

Multivalent nanoemulsion vaccines

 #253
20120107345
2012-05-03

Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant

 #254
20120091026
2012-04-19

Method of storing a vaccine containing an aluminum adjuvant

 #255
20120087946
2012-04-12

Recombinant bacterium and methods of antigen and nucleic acid delivery

 #256
20120045511
2012-02-23

THERMOSENSITIVE HEPATITIS B VACCINE

 #257
20120039842
2012-02-16

Compositions and methods that enhance an immune response

 #258
20120027795
2012-02-02

SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES

 #259
20120010394
2012-01-12

Immunogen platform

 #260
20110311574
2011-12-22

Multiple vaccination including serogroup C Meningococcus

 #261
20110293649
2011-12-01

In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles

 #262
20110281292
2011-11-17

Compositions and methods for identifying antigens which elicit an immune response

 #263
20110263822
2011-10-27

COMPOSITION FOR THE PROPHYLAXIS AND TREATMENT OF HBV INFECTIONS AND HBV-MEDIATED DISEASES

 #264
20110257080
2011-10-20

Hepatitis B virus compositions and methods of use

 #265
20110243971
2011-10-06

Vaccines

 #266
20110212159
2011-09-01

Vaccines

 #267
20110212124
2011-09-01

Vaccine Composition

 #268
20110206758
2011-08-25

Vaccine compositions comprising a saponin adjuvant

 #269
20110206726
2011-08-25

Combination vaccine with acellular pertussis

 #270
20110195087
2011-08-11

COMBINATION VACCINE WITH WHOLE CELL PERTUSSIS

 #271
20110189180
2011-08-04

Antigenic compositions and use of same in the targeted delivery of nucleic acids

 #272
20110182939
2011-07-28

Farnesoid-X-receptor antagonist as a vaccine adjuvant

 #273
20110165194
2011-07-07

HBV vaccine and a process of preparing the same

 #274
20110159047
2011-06-30

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

 #275
20110150922
2011-06-23

Immunogen platform

 #276
20110150921
2011-06-23

Fusion proteins and use thereof for preparing hepatitis C vaccines

 #277
20110142869
2011-06-16

Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine

 #278
20110129496
2011-06-02

Use of mTOR inhibitors to enhance T cell immune responses

 #279
20110129489
2011-06-02

METHODS FOR GENERATING AN IMMUNE RESPONSE USING DNA AND A VIRAL VECTOR

 #280
20110110974
2011-05-12

METHODS AND KITS FOR INDUCING A CTL RESPONSE USING A PRIME BOOST REGIMEN

 #281
20110091501
2011-04-21

Recombinant Rhinovirus Vectors

 #282
20110082287
2011-04-07

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #283
20110081381
2011-04-07

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #284
20110065174
2011-03-17

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #285
20110059132
2011-03-10

COMPOSITION FOR THERAPY AND/OR FOR PROPHYLAXIS OF HBV-INFECTIONS AND HBV-MEDIATED DISEASES

 #286
20110059116
2011-03-10

LASER-BASED VACCINE ADJUVANTS

 #287
20110027318
2011-02-03

NUCLEOTIDE VECTOR, COMPOSITION CONTAINING SUCH VECTOR, AND VACCINE FOR IMMUNIZATION AGAINST HEPATITIS

 #288
20110020397
2011-01-27

Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors

 #289
20100322891
2010-12-23

Immuniostimulating polyphosphazene compounds

 #290
20100316669
2010-12-16

Vaccine formulation potentiated by the combination of DNA and an antigen

 #291
20100313298
2010-12-09

EXPRESSION CASSETTE, T-DNA MOLECULE, PLANT EXPRESSION VECTOR, TRANSGENIC PLANT CELL AS WELL AS THEIR USE IN THE MANUFACTURING OF A VACCINE

 #292
20100310656
2010-12-09

Immunotherapy and prevention of autoimmune hepatitis

 #293
20100297170
2010-11-25

Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule

 #294
20100272805
2010-10-28

HYDROGELS FOR COMBINATORIAL DELIVERY OF IMMUNE-MODULATING BIOMOLECULES

 #295
20100266672
2010-10-21

VACCINES

 #296
20100260806
2010-10-14

Nucleic acids encoding antibodies or portions thereof comprising a heterologous T cell epitope and their use in modulating T cell responses

 #297
20100233201
2010-09-16

Polyanionic polymer adjuvants for B saccharide vaccines

 #298
20100226937
2010-09-09

COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE

 #299
20100215686
2010-08-26

Process for manufacturing vaccines

 #300
20100203074
2010-08-12

COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR DISEASES